Effect of Liraglutide on Arterial Inflammation Assessed as [(18)F]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

The mechanism behind the cardiovascular protection observed with human GLP-1 RA (glucagon-like peptide-1 receptor agonists) in type 2 diabetes is unknown. We hypothesized that treatment with the GLP-1 RA liraglutide had a positive effect on vascular inflammation. METHODS: LIRAFLAME (Effect of liragl...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Circ Cardiovasc Imaging
Hlavní autoři: Ripa, Rasmus S., Zobel, Emilie H., von Scholten, Bernt J., Jensen, Jacob K., Binderup, Tina, Diaz, Lars J., Curovic, Viktor R., Hansen, Tine W., Rossing, Peter, Kjaer, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2021
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300846/
https://ncbi.nlm.nih.gov/pubmed/34187185
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCIMAGING.120.012174
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky